IL116734A0 - 2-methylaminoindanes - Google Patents

2-methylaminoindanes

Info

Publication number
IL116734A0
IL116734A0 IL11673496A IL11673496A IL116734A0 IL 116734 A0 IL116734 A0 IL 116734A0 IL 11673496 A IL11673496 A IL 11673496A IL 11673496 A IL11673496 A IL 11673496A IL 116734 A0 IL116734 A0 IL 116734A0
Authority
IL
Israel
Prior art keywords
methylaminoindanes
Prior art date
Application number
IL11673496A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL116734A0 publication Critical patent/IL116734A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11673496A 1995-01-13 1996-01-11 2-methylaminoindanes IL116734A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9500691.2A GB9500691D0 (en) 1995-01-13 1995-01-13 Compounds

Publications (1)

Publication Number Publication Date
IL116734A0 true IL116734A0 (en) 1997-08-14

Family

ID=10768011

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11673496A IL116734A0 (en) 1995-01-13 1996-01-11 2-methylaminoindanes

Country Status (10)

Country Link
US (1) US5863952A (ja)
EP (1) EP0802899A1 (ja)
JP (1) JPH10512252A (ja)
AU (1) AU4537596A (ja)
CO (1) CO4700282A1 (ja)
GB (1) GB9500691D0 (ja)
IL (1) IL116734A0 (ja)
MA (1) MA23772A1 (ja)
WO (1) WO1996021641A1 (ja)
ZA (1) ZA96203B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518572D0 (en) * 1995-09-12 1995-11-15 Smithkline Beecham Plc Compounds
US6620848B2 (en) * 1997-01-13 2003-09-16 Smithkline Beecham Corporation Nitric oxide synthase inhibitors
AU1600599A (en) 1998-02-27 1999-09-15 Warner-Lambert Company Heterocyclic substituted aniline calcium channel blockers
US6166052A (en) * 1998-03-11 2000-12-26 Warner-Lambert Company Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers
WO2000021550A2 (en) * 1998-10-13 2000-04-20 President And Fellows Of Harvard College Methods and compositions for treating neurodegenerative diseases
MY125533A (en) * 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
CA2421801C (en) * 2003-03-13 2010-02-23 Denfred Holdings Ltd. Automatic valve assembly for a water cooler reservoir
WO2005037286A1 (en) * 2003-03-25 2005-04-28 Vasopharm Biotech Gmbh Use of pteridine derivatives for the treatment of increased intracranial pressure and secondary ischemia
KR101277520B1 (ko) * 2004-09-10 2013-06-21 뉴론 파마슈티칼즈 에스. 피. 에이. （할로벤질옥시）벤질아미노－프로판아미드를 포함하는 선택적 나트륨 및／또는 칼슘 채널 조절제로서 유용한 약제학적 조성물
RU2397160C9 (ru) 2005-12-22 2012-10-27 НЬЮРОН ФАРМАСЬЮТИКАЛЗ С.п.А. 2-фенилэтиламинопроизводные в качестве модуляторов кальциевых и/или натриевых каналов
HUE038113T2 (hu) 2007-06-15 2018-09-28 Newron Pharm Spa Helyettesített 2-[2-(fenil)-etilamino]-alkánamid-származékok és alkalmazásuk nátrium- és/vagy kalciumcsatorna-modulátorokként
ES2602140T3 (es) 2011-06-27 2017-02-17 Newron Pharmaceuticals S.P.A. Derivados de arilalquilaminocarboxamida fluorados

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9315600D0 (en) * 1993-07-28 1993-09-08 Smithkline Beecham Plc Compounds
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

Also Published As

Publication number Publication date
CO4700282A1 (es) 1998-12-29
WO1996021641A1 (en) 1996-07-18
AU4537596A (en) 1996-07-31
GB9500691D0 (en) 1995-03-08
MA23772A1 (fr) 1996-10-01
EP0802899A1 (en) 1997-10-29
US5863952A (en) 1999-01-26
ZA96203B (en) 1997-07-11
JPH10512252A (ja) 1998-11-24

Similar Documents

Publication Publication Date Title
DE69513693D1 (en) Positions-servo-system
DE59607964D1 (en) Oxymethoxy-3-aryl-pyron-derivate
DE59607241D1 (en) Endotracheal-tubus
DE69608292D1 (en) Audio-synthesizer
DE69606427D1 (en) Hydroformylierungsverfahren
DE69611623D1 (en) Polyurethanelastomere
DE69616581D1 (en) Polyurethanhartschäume
DE69610843D1 (en) Hydroformylierungsverfahren
DE69516545D1 (en) Polyacetalharzzusammensetzung
DE59610991D1 (en) Cyclopeptidderivate
IL116734A0 (en) 2-methylaminoindanes
DE59608164D1 (en) Cyclohexenonoximether-metallsalze
DE59602888D1 (en) Breitstreckaggregat
DE59605001D1 (en) Luftreinigungsgerät
DE59602283D1 (en) Inchbremseinrichtung
DE59602030D1 (en) Zellige polyurethan-elastomere
DE69612563D1 (en) Hydroformylierungsverfahren
DE69611833D1 (en) Carbonylierungsreaktionen
DE59505396D1 (en) Handhobelmaschine
DE69610077D1 (en) Sesquiterpenverbindungen
AP9600802A0 (en) Libricant
DE59604506D1 (en) Rückkühlsystem
DE59600830D1 (en) Breitstrahldüse
DE59604913D1 (en) Carbonylverbindungen
DE59609059D1 (en) Conventional-direct-glazing